Clinical Trials Directory

Trials / Terminated

TerminatedNCT00637858

Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects

Effect of Different Doses of Tomato Lycopene on the Blood Pressure in Prehypertensives and Grade I Never Treated Otherwise Healthy Subjects

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

Effect of different doses of tomato extract (contain Lyc-o-Mato 6% Oleoresin which Contain: 5, 15 mg lycopene , in addition to Beta-carotene (0.15%), phytoene, and phytofluene (1%); and vitamin E (2%), phospholipids (15%), and phytosterols (0.6%) suspended in tomato oleoresin oil) compared with synthetic lycopene on blood pressure and plasma lycopene levels in never treated pre-hypertensive otherwise healthy subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLyc-O-Mato 5mgDaily Lyc-O-Mato 5mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule
DIETARY_SUPPLEMENTLyc-O-Mato 15mgDaily Lyc-O-Mato 15mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule
DIETARY_SUPPLEMENTLyc-O-Mato 30mgDaily Lyc-O-Mato 30mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule
DIETARY_SUPPLEMENTLycopene capsules (non Lyc-o-mato) 15 mgDaily Lycopene capsules (non Lyc-o-mato) 15 mg with lunch for 8 weeks (After 4 weeks of placebo run in).
OTHERPlaceboPlacebo capsules, identical looking to previous capsules for double-blind treatment period (8 weeks) and single blind run-in (4 weeks).

Timeline

Start date
2008-10-01
Primary completion
2009-12-01
Completion
2011-01-01
First posted
2008-03-18
Last updated
2013-01-08

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00637858. Inclusion in this directory is not an endorsement.